China News Service, September 22 (Chen Jing, Tang Jing) The reporter learned on the 22nd that Chen Kaixian, a tenured professor of Shanghai University of Traditional Chinese Medicine and academician of the Chinese Academy of Sciences, and Professor Chen Hongzhuan of the school were invited to co-author the paper "Chinese Medicine Prevents COVID-19" in English The comprehensive medical journal "Frontiers of Medicine" was published online.
The review "my country's Traditional Chinese and Western Medicine Coordinating Prevention and Treatment of New Coronary Pneumonia" written by the team of Professor Chen Hongzhu of the school was published as the opening paper of the "Anti-epidemic Special Issue" of the English Journal of Pharmaceutical Sciences (APSB).
The paper by Chinese experts pointed out that the successful experience of early detection, early isolation, early treatment and integration of traditional Chinese and Western medicine has contributed to China's rapid containment of the COVID-19 epidemic.
They suggested in the paper that we should further cross-discipline, including the use of new technologies and methods in information science, systems biology, and complexity science to better study the multi-component, quality control and multi-target effects of traditional Chinese medicine. Continue to develop ancient Chinese medicine and make new contributions to human health.
Chinese experts pointed out that early Chinese medicine interventions for patients with new coronary pneumonia not only have preventive advantages, but can also treat the disease in a personalized and multi-targeted manner.
Paper screenshot
According to reports, the above-mentioned papers systematically explained the scientific connotation of Chinese traditional Chinese medicine for the prevention and treatment of new coronary pneumonia, and explored feasible methods and paths for the prevention and treatment of new outbreaks of infectious diseases in the future.
The school stated that the publication of the summary and results of TCM prevention and treatment of new coronary pneumonia in well-known academic journals is of great significance to promoting the inheritance, innovation and internationalization of TCM.
According to a paper co-authored by Chen Kaixian and Chen Hongzhuan, the novel coronavirus pneumonia (COVID-19) is a highly pathogenic infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Due to its unique characteristics of etiology, epidemiology and pathology, diagnosis and treatment are extremely challenging.
It is reported that in response to the new crown epidemic, the third edition of the "New Coronavirus Pneumonia Diagnosis and Treatment Plan" issued by the National Health and Medical Commission first proposed a Chinese medicine treatment plan. In subsequent editions of the diagnosis and treatment plan, the Chinese medicine treatment plan has been continuously revised and upgraded.
Chen Kaixian said that early Chinese medicine interventions for patients with new coronary pneumonia not only have preventive advantages, but can also treat the disease in a personalized and multi-targeted manner, such as speeding up the improvement of patients’ symptoms, preventing mild or moderate cases from developing into severe illness, and helping to alleviate the public’s Panic and anxiety etc.
The paper pointed out that Zhang Boli, an academician of the Chinese Academy of Engineering, used Chinese medicine to treat patients with new crowns in Jiangxia Fangcai Hospital; academician of the Chinese Academy of Sciences Tong Xiaolin's "Wuchang Model", through the treatment of Chinese medicine, "strangled most of the symptoms of new coronary pneumonia in the early stage"; Huang Luqi, academician of the Chinese Academy of Engineering The interpretation of the unique advantages of the "three medicines and three prescriptions" that played a key role in the treatment of new coronary pneumonia has confirmed the unique contribution of traditional Chinese medicine in quickly curbing the COVID-19 epidemic.
At the beginning of the new crown pneumonia epidemic, Shanghai University of Traditional Chinese Medicine established a new coronavirus emergency scientific research leading group to arrange research projects on the prevention and treatment of COVID-19 in Chinese medicine, and successively received support from the major research plans of the Ministry of Science and Technology.
The school established a Chinese medicine emergency research team led by Professor Chen Hongzhuan, and the PI team of the Interdisciplinary Research Institute, the Institute of Innovative Chinese Medicine, the Institute of Chinese Medicine, and the School of Basic Medical Sciences collaborated on the research, and systematically carried out the substances in the national plan "Qingfei Paidu Decoction" Basic and pharmacological research, etc.
The thesis written by the team of Professor Chen Hongzhuan systematically expounded the theory and historical experience of Chinese medicine in preventing and curing diseases, and conducted in-depth discussions from the "virus-environment-human" interaction and pharmacological mechanisms.
It is understood that at the beginning of the new crown pneumonia epidemic, Chen Hongzhu’s team actively constructed an antiviral drug screening model, and took the lead in revealing the interaction mechanism of relevant Chinese medicine active ingredients to inhibit key viral targets.
At the same time, researchers are actively carrying out clinical research on the treatment of new coronary pneumonia with traditional Chinese and Western medicine. Based on historical experience, they explore the successful experience of Chinese traditional Chinese and Western medicine in fighting the epidemic, and reveal the law of traditional Chinese medicine in the treatment of infectious diseases from the perspective of pharmacology.
During the interview, the reporter learned that previously, Shanghai University of Traditional Chinese Medicine was invited by the World Federation of Chinese Medicine Societies to preside over the translation of the seventh edition of the Chinese Medicine section of the National Health Commission's "New Coronavirus Pneumonia Diagnosis and Treatment Plan" to share the Chinese plan with the world. , Highly praised by domestic and foreign counterparts.
42 Chinese medicine anti-epidemic studies by scholars of this school were successfully selected into the World Health Organization (WHO) COVID-19 database, sharing the experience of Chinese medicine in the prevention and treatment of new crowns with the world.